(Q37132001)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Suppression of lung cancer in murine model: treated by combination of recombinant human endostsatin adenovirus with low-dose cisplatin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

1 reference

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Rui Z Bai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Yang Wu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Quan Liu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ke Xie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Yu Q Wei

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Yong S Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Kang Liu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Yan Luo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Jing M Su

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ji Y Liu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Qiu Li

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ting Niu

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Zhi W Zhao

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Li Yang

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

5 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

Journal of Experimental & Clinical Cancer Research

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

Antiangiogenesis in haematological malignancies.

22 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Bevacizumab in the treatment of breast cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Targeting angiogenesis in the treatment of lung cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Cellular and molecular surrogate markers to monitor targeted and non-targeted antiangiogenic drug activity and determine optimal biologic dose

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Redefining the target: chemotherapeutics as antiangiogenics

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Endostatin, an antiangiogenic protein, is expressed in the unilateral ureteral obstruction mice model

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Anti-angiogenic gene therapy for metastatic renal cell carcinoma produces tumor growth suppression in an athymic nude mouse model

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Intra-arterial delivery of endostatin gene to brain tumors prolongs survival and alters tumor vessel ultrastructure

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: time to take stock!

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2657125

Chemotherapy and antiangiogenesis--drug-specific, dose-related effects

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1756-9966-28-31

Cisplatin triggers platelet activation

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19265510

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1756-9966-28-31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

22 January 2020

1018619264

0 references

Fatcat ID

release_nwkm3ywvwnaxnpbbv6bxpgsjoy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nwkm3ywvwnaxnpbbv6bxpgsjoy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19265510%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

19265510

1 reference